Contact
Please use this form to send email to PR contact of this press release:
GSK gains accelerated FDA approval for combination use of Mekinist® (trametinib) and Tafinlar® (dabrafenib)
TO:
Please use this form to send email to PR contact of this press release:
GSK gains accelerated FDA approval for combination use of Mekinist® (trametinib) and Tafinlar® (dabrafenib)
TO: